Clinical Trial Update: A Phase III Study of SHR-8068 in Combination With Adebrelimab and Platinum-Containing Chemotherapy Versus Durvalumab in Combination With Platinum-Containing Chemotherapy as First-line Treatment for Advanced Biliary Tract Cancer (BTC) [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating SHR-8068 plus Adebrelimab and platinum-containing chemotherapy versus Durvalumab plus platinum-containing chemotherapy as first-line …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer

Drugs mentioned

• Adebrelimab (adebrelimab)
• Durvalumab (durvalumab)
• SHR-8068

Snippet

Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. | Conditions: Advanced Biliary Tract Cancer | Phase 3 | Status: RECRUITING